Schenker H I, Yablonski M E, Podos S M, Linder L
Arch Ophthalmol. 1981 Jul;99(7):1212-6. doi: 10.1001/archopht.1981.03930020086007.
The action and interaction of topical 2% epinephrine hydrochloride and 0.5% timolol maleate therapy were studied in 12 normal and 16 ocular hypertensive subjects. Measurements of intraocular pressure, outflow facility, and aqueous secretion by fluorophotometry were made. Uveoscleral outflow values were calculated. Epinephrine, applied topically twice daily for one week, resulted in a decrease in IOP of 3.3 +/- 0.9 mm Hg and an increase in outflow facility of 0.05 +/- 0.01 microL/min/mm Hg, as well as an increase in the rate of aqueous production of 0.32 +/- 0.09 microL/min. Uveoscleral outflow showed an increase of 0.83 +/- 0.23 microL/min. Timolol, applied topically twice daily for one week, reduced the IOP 3.9 +/- 1.0 mm Hg and decreased aqueous flow 0.84 +/- 0.23 microL/min, but produced no change in outflow facility or uveoscleral flow. When epinephrine and timolol are given in combination, the effects in lowering IOP may not be completely additive.
对12名正常受试者和16名高眼压受试者研究了局部应用2%盐酸肾上腺素和0.5%马来酸噻吗洛尔治疗的作用及相互作用。通过荧光光度法测量眼压、房水流畅系数和房水分泌。计算葡萄膜巩膜流出值。每天局部应用肾上腺素两次,持续一周,眼压降低3.3±0.9 mmHg,房水流畅系数增加0.05±0.01 μL/min/mmHg,房水生成率增加0.32±0.09 μL/min。葡萄膜巩膜流出增加0.83±0.23 μL/min。每天局部应用噻吗洛尔两次,持续一周,眼压降低3.9±1.0 mmHg,房水流量减少0.84±0.23 μL/min,但房水流畅系数和葡萄膜巩膜流量无变化。当联合应用肾上腺素和噻吗洛尔时,降低眼压的效果可能并非完全相加。